Monitor: Molecules and profiles

Drug Discovery Today

Volumn 5, Issue 8, 2000, Pages 373-375

  Lloyd, Andrew W ^a  

^a UNIVERSITY OF BRIGHTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; ANTIRHEUMATIC AGENT; BENZOFURAN DERIVATIVE; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; INTERLEUKIN 10; MATRIX METALLOPROTEINASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PARECOXIB; QUINONE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

CANCER; DRUG DESIGN; DRUG DEVELOPMENT; NONHUMAN; SHORT SURVEY; STRUCTURE ACTIVITY RELATION;

EID: 0034256072     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(00)01533-6     Document Type: Short Survey

References (7)

1. Nebois P.et al. Quinonic derivatives active against a virulent strain of Toxoplasma gondii. Synthesis of 2-methylfuro[2,3-g]- and [3,2-g]isoquinolinetriones. Bioorg. Med. Chem. Lett. 10:2000;871-873.
2. Hanano T.et al. Novel phenylpiperazine derivatives as dual cytokine regulators with TNFα suppressing and IL-10 augmenting activity. Bioorg. Med. Chem. Lett. 10:2000;875-879.
3. Hanano T.et al. Novel DMARDs on the basis of a new concept of dual cytokine regulation, TNFα suppression and IL-10 augmentation activity. Bioorg. Med. Chem. Lett. 10:2000;881-884.
4. Talley J.J.et al. N-[(5-methyl-3-phenylisoxazol-4-yl)-phenyl]sulfonyl]-propanamide, sodium salt, parecoxib sodium: a potent and selective inhibitor of COX-2 for parenteral administration. J. Med. Chem. 43:2000;1661-1663.
5. Clark A.F.et al. Ocular angiostatic agents. Exp. Opin. Ther. Patents. 10:2000;427-448.
6. Uckun F.M.et al. A rationally designed anticancer drug targeting a unique binding cavity of tubulin. Bioorg. Med. Chem. Lett. 10:2000;1015-1018.
7. 1-adrenergic receptor antagonists. Bioorg. Med. Chem. Lett. 10:2000;1093-1096.